Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe

Table 2 Efficacy of a single oral dose of Simparica Trio™ and afoxolaner+ milbemycin oxime against natural flea infestations across all flea species on dogs presented as veterinary patients in Europe

Study day	Treatment group	n	Live flea counts		% Efficacy
Study day	Treatment group	n	Range	Arithmetic mean	% Efficacy
− 1 to 0	Simparica Trio™	176	5–111	12.2	–
− 1 to 0	Afoxolaner + Milbemycin oxime	95	5–59	10.4	–
14 ± 5	Simparica Trio™	174	0–11	0.2	97.9
14 ± 5	Afoxolaner + Milbemycin oxime	91	0–12	0.5	96.1
30 ± 5	Simparica Trio™	170	0–17	0.2	98.6
30 ± 5	Afoxolaner + Milbemycin oxime	91	0–4	0.2	98.7

ISSN: 1756-3305